The Value of Cancer Treatment Today

PhRMA

In recent decades, tremendous progress has been made in the fight against cancer. Continued research has expanded our knowledge of how the disease develops and how to target medicines for specific cancer types – resulting in more effective therapies for patients. Biopharmaceutical companies are developing 836 medicines and vaccines for cancer, all of which are in clinical trials or awaiting review by the U.S. Food and Drug Administration (FDA).

 

Key Facts About Cancer

 

Latest From TheBlog

ICYMI: More than 60 PhRMA company scientists visit Capitol Hill

By Andrew Powaleny on September 30, 2016 at 09:00 AM

Eradication of measles highlights the promise of vaccines in development

By Hannah Mooney on September 29, 2016 at 03:31 PM

Celebrating hope for patients and families on World Heart Day 2016

By Hannah Mooney on September 29, 2016 at 09:27 AM

4 recommendations for ICER

By Lauren Neves on September 26, 2016 at 03:17 PM